Chun Zeng

Chun Zeng is a Senior Scientist in Process Development at Fate Therapeutics Inc. since September 2021, specializing in novel NK cell-based adoptive immunotherapies for relapsed/refractory hematologic malignancies. Prior to this role, Chun Zeng served as a Scientist in Analytical Development at Takeda from August 2020 to September 2021, focusing on CAR-NK cell-based therapies. Previous experience includes an Assistant Project Scientist position at UCSD, where work involved diabetes disease modeling using stem cell differentiation, and two postdoctoral researcher roles at UCSD and UCLA focusing on pancreatic beta cell regeneration and proliferation utilizing transgenic mice and single cell technologies. Chun Zeng holds a Ph.D. in Cell Biology from the Institute of Zoology, Chinese Academy of Sciences, and a Bachelor of Medicine from Peking University.